Podcasts about Moderna

Today marks one year since President Trump began his second term. In just one year, we've seen seismic shifts in America's foreign policy, such as his relentless bid for Greenland. Plus, he's now threatening an additional 200% tariffs on French wine if Macron refuses to join his Gaza Board of Peace. Democratic Senator Chris Coons wants to de-escalate tensions and has just finished a bipartisan congressional visit to Denmark. He joins the show from Davos.  Also on today's show: CNN Jerusalem correspondent Jeremy Diamond; NYT columnist Lydia Polgreen; Noubar Afeyan, Co-founder, Moderna    Learn more about your ad choices. Visit podcastchoices.com/adchoices

Intelligence Notes:LAWSUIT: Genomic Warfare Confirmed-Monsanto Technology in your COVID SHOTS 2026- New World Order.Pharmaceutical Warfare: Bayer, ModeRNA, Pfizer et al.To support the [Show] and its [Research] with Donations, please send all funds and gifts to :$aigner2019 (cashapp) or https://www.paypal.me/Aigner2019 or Zelle (1-617-821-3168). Shalom Aleikhem!

New research is transforming the outlook for cervical and uterine cancers -- two of the most serious gynecologic malignancies worldwide – and we'll be hearing from one of the people shaping that progress, Dr. Mary McCormack, on this episode of Raise the Line. From her perch as the senior clinical oncologist for gynecological cancer at University College London Hospitals, Dr. McCormack has been a driving force in clinical research in the field, most notably as leader of the influential INTERLACE study, which changed global practice in the treatment of locally advanced cervical cancer, a key reason she was named to Time Magazine's 2025 list of the 100 most influential people in health. “In general, the protocol has been well received and it was adopted into the National Comprehensive Cancer Network guidelines which is a really big deal because lots of centers, particularly in South and Central America and Southeast Asia, follow the NCCN's lead.”In this conversation with host Michael Carrese, you'll learn about how Dr. McCormack overcame recruitment and funding challenges, the need for greater access to and affordability of treatments, and what lies ahead for women's cancer treatment worldwide. Mentioned in this episode:INTERLACE Cervical Cancer Trial If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Ander Tallet, co-founder and COO of Dash Bio and CEO of DigitalRadius, joins Ross Katz to discuss transforming the traditional CRO model through automation, transparency, and productization. Drawing on deep experience from Moderna, Science Exchange, and his leadership roles in digital transformation, Ander shares how Dash Bio is slashing turnaround times, improving data quality, and simplifying procurement for biotech companies. This episode unpacks the future of CRO services, strategic procurement, and the power of operational innovation in biotech. What you'll learn in this episode: >> Why traditional CRO models hinder speed and transparency in biotech >> How Dash Bio delivers 90% faster turnaround through automation >> What productizing CRO services really means for the customer experience >> How regulatory requirements shape innovation in clinical bioanalysis >> Why investor buy-in requires solving real, painful problems in biotech Meet our guest Ander Tallett is the co-founder and COO of Dash Bio and the CEO of DigitalRadius, where he leads digital transformation initiatives as one of the largest Smartsheet partners in the ecosystem. He previously served as Chief Strategy Officer at Science Exchange and co-founded Block Mill Capital, a B2B SaaS-focused investment fund shaped by his experience evaluating and implementing more than 100 SaaS platforms.  About the host Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation. Connect with our guest: Sponsor: CorrDyn, a data consultancyConnect with Ander Tallet on LinkedIn  Connect with us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode!Connect with Ross Katz on LinkedIn Sponsored by… This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.

Ven al primer directo del podcast en Madrid, entradas a la venta aquí: https://entradas.grupomarquina.es/grupomarquina/events/50528?sessionView=LIST En este episodio del podcast, hablamos con Jorge Darek sobre nutrición natural, salud real y los hábitos modernos que están afectando silenciosamente a nuestro bienestar. A lo largo de la entrevista, Jorge cuestiona muchas creencias aceptadas sobre alimentación saludable, rutinas diarias, productos ultraprocesados y el estilo de vida actual, poniendo el foco en un enemigo común: el estrés crónico y la desconexión con lo natural.Si te interesa mejorar tu salud, recuperar energía, romper dogmas y entender la nutrición desde una perspectiva más natural y realista, este episodio es para ti.

Enterprise AI adoption is still stuck in the teens and the gap between the hype and the reality is getting harder to ignore. People are finding pockets of productivity, but they're often keeping the gains to themselves, worried that “using AI well” is just speed-running their way into a layoff. Meanwhile, many leaders treat it like another piece of software without touching the messier truth: AI changes how work actually happens, and it doesn't care about your org chart, your approval chains, or your performance theater. In this episode, Rodney sits down with Section CEO Greg Shove to name what's really blocking adoption and what it takes to break through. They talk about AI as “co-intelligence”, why most “AI layoffs” are PR cover, and the non-negotiables for real transformation. They also get into how to build a robust AI strategy for 2026, Section's own AI disruption, and why the next era may be dominated by super companies built around small human teams + a fleet of agents. Learn more about Greg: His website Section's website Prof.AI AI Truth Serum podcast -------------------------------- Ready to change your organization? ⁠⁠⁠⁠⁠⁠Let's talk.⁠⁠⁠⁠⁠⁠ Get our newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.⁠⁠⁠⁠⁠⁠ Follow us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ -------------------------------- Mentioned references: Edelman's AI creators Chegg's downfall Moderna's AI usage Zapier's AI usage BOX's AI usage Dual Transformation Skunk Works Mary Barra "amazon.bomb" Stanford AI study 00:00 Intro + Check-In: What's something happening in the AI hype cycle that drives you nuts right now? 03:21 Enterprise AI adoption stall out 08:58 AI as truth serum for lies in your company 11:49 Required ingredients for real AI transformation 19:04 Balancing risk with AI usage in startups and large enterprise 24:10 “Head of AI” roles are an uphill battle 27:48 First principles for an AI-lead organization 30:10 Disrupting your business model with AI and dual transformation 35:29 Greg and Section disrupting themselves with AI 37:44 Role of leadership in an AI future 44:40 Future of companies and careers 47:54 Role of companies in future of society 52:07 Wrap up: Leave us a review and share the show with a coworker! Sound engineering and design by Taylor Marvin of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Coupe Studios⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

En este episodio retomamos la conversación con Rodrigo Castilla de Citrus Patrimonial para analizar qué ha pasado después del primer capítulo: crecimiento de inversionistas, evolución del precio del limón, expansión internacional y los retos reales de escalar un negocio del campo.Hablamos de invertir en producción, no en activos financieros tradicionales; de rendimientos ligados al mercado real; de exportación, logística, fideicomisos, visión de largo plazo y por qué el campo exige paciencia, estrategia y ejecución impecable. Un episodio para entender cómo se construye un negocio sólido cuando los resultados no llegan mañana… pero pueden durar generaciones.

“The world is a very volatile place, with currently 110 conflicts globally, and yet healthcare staff in the hospitals, even here in London, are not prepared to be the only clinician who can help in a crisis or hostile setting,” says Dr. David Gough, CEO of the David Nott Foundation, which equips providers with the skills and confidence needed to function in war and other extraordinary situations. A former British Army doctor injured in Afghanistan, Gough brings lived experience as well as a background in tech to his current role at the Foundation, which itself is anchored in decades of field work amassed by its namesake, a renowned war surgeon. As Dr. Gough points out to host Lindsey Smith, the cause could be helped by augmenting medical school curricula, but in the meantime, the Foundation is filling the knowledge gap by using prosthetics, virtual reality simulations and cadavers to train a broad swath of health workers including surgeons, anesthetists, and obstetricians. Tune in to this important Raise the Line conversation as Dr. Gough reflects on the strengths and weaknesses of NGOs in doing this work, his plans to expand the Foundation's footprint in the US, and the gratifying feedback he's received from trainees now operating on the frontlines in Ukraine and elsewhere. Mentioned in this episode:David Nott Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

En este episodio me senté con Johnny Abraham para hablar sin rodeos sobre el amor moderno, la soltería, los roles en pareja, el dinero y por qué cada vez es más difícil construir relaciones duraderas.Platicamos sobre la lucha de poder entre hombres y mujeres, el miedo al compromiso, la obsesión por evitar el proceso, el impacto de las apps de citas y cómo muchas decisiones se están tomando desde la herida, no desde la elección consciente. Un episodio para cuestionar si estamos buscando equipo… o solo comodidad, y por qué el equilibrio, la comunicación y la responsabilidad siguen siendo clave para una relación sana.

Recibe tu curso gratis aquí: https://www.hombrealfa.top/curso-gratis/ Únete a los miles de hombres que forman parte de mi comunidad de email para acceder a promociones exclusivas y enterarte de la apertura de mis formaciones. Estar suscrito tiene premio y es la única manera de estar al día de las novedades del proyecto. Al suscribirte con tu email, recibes el curso gratis de «Cómo ser un hombre más atractivo e interesante para las mujeres en la era de las apps y las redes sociales». Es un curso de siete lecciones por escrito (no vídeo, no audio) que puedes personalizar en función del momento que estés viviendo en tus relaciones. Para unirte a mi comunidad y recibir el curso, deja tu email en el enlace: https://www.hombrealfa.top/curso-gratis/ *¿Qué aprenderás en este episodio?: 1) Por qué culpar al apego o al narcisismo es el nuevo ""tengo metabolismo lento"". 2) La verdadera historia de la teoría del apego y lo que de verdad intentaba explicar. 3) Por qué las etiquetas de Instagram NO explican tu fracaso relacional (aunque suenen bonito). 4) El gran error de pensar que tu estilo de apego determina tu atracción o éxito con las mujeres. 5) La razón por la que te aferras a relaciones mediocres… y la biología que lo explica mejor que cualquier test de apego. En el Episodio de hoy desmontamos la creencia más extendida (y equivocada) de la psicología pop moderna: que tu estilo de apego determina por qué tus relaciones fracasan. Analizamos su origen clínico real, lo que Bowlby y Ainsworth realmente investigaban y cómo se ha pervertido el mensaje original para justificar dinámicas desequilibradas Además, veremos por qué pensar que “soy ansioso” o “ella es evitativa” es una anestesia narrativa que te aleja de ver la raíz real del problema: una dinámica de poder, valor y escasez en la que la biología tiene mucho más que decir que cualquier etiqueta emocional. PD. Recibe tu curso gratis aquí: https://www.hombrealfa.top/curso-gratis/

Dos formaciones del pianista brasileño Benjamim Taubkin en su sello Núcleo Contemporáneo: Moderna Tradição ('Lamentos' de Pixinguinha y 'Lamentos do morro' de Garoto) y Orquestra Popular de Câmara ('Bayati' y 'Correnteza' -ambas con la voz de Mònica Salmaso- y 'Choro moreno'). Del disco que Mônica grabó con su nombre en 1999, 'Voadeira', las canciones 'Dançapé', 'Valsinha' de Vinicius de Moraes y Chico Buarque y 'Ave Maria no morro' de Herivelto Martins y, de 'Canto sedutor', que firmó en 2022 con Dori Caymmi, 'Desenredo'. Escuchar audio

2011 utbryter panik i den internationella konstvärlden. Wolfgang Beltracchi har under fyra decennier målat och sålt förfalskningar för hundratals miljoner kronor. Lyssna på alla avsnitt i Sveriges Radios app. På 90-talet dyker det upp försvunna tavlor av de världsberömda konstnärerna Max Ernst och Heinrich Campendonk. Verk som ska ha funnits, men som ingen har sett på 100 år. I själva verket är det konstnären Wolfgang Beltracchi som målat tavlorna. Han har hittat ett slags blind fläck på konstmarknaden genom att gå igenom mängder av konstkataloger. Adolf Hitler gillade inte modern konst och under naziregimen försvann tusentals verk. Och det är dom här verken som Wolfgang Beltracchi målar, som om de vore de äkta tavlorna. I nära 40 år kan Wolfgang tjäna mångmiljonbelopp på sina förfalskningar. Men en dag tar det stopp. Moderna museet lurades år 2008Wolfgang Beltracchis förfalskningar visas upp världen över – till och med i Sverige. För första gången kommenterar Moderna museet i Stockholm det faktum att de ovetandes ställde ut en av Wolfgang Beltracchi målad Max Ernst-tavla. Medverkande:Wolfgang Beltracchi, konstnären som målat förfalskningarna.Helena Beltracchi, Wolfgangs hustru och medhjälpare i förfalskningarna. Iris Müller Westermann, senior curator på Moderna Museet i Stockholm.Thomas Seydoux, tidigare senior konstexpert på auktionshuset Christie's i London.Sofia Komarova, driver galleriet Artvera's i Geneve i Schweiz.René Allonge, poliskommissarie som leder specialenheten för konstbrottslighet i Berlin.Nicolas Eastaugh, konstanalytiker och grundare av det globala konstananalyscentret VersariK.En dokumentär av Alexandra SannemalmProducent: Hannah EngbergExekutiv producent på Sveriges radio: Tove PalénDokumentären är producerad 2025.

Filho de britânicos, Derek Prince nasceu em 1915, na Índia. Estudou Filosofia Antiga e Moderna no Kings College, além de línguas, como hebraico e aramaico, na Universidade de Cambridge e na Universidade Hebraica de Jerusalém. Em julho de 1941, Derek teve o que ele descreveu como uma “experiência sobrenatural”, um encontro com Jesus que o levou à seguinte declaração: “Eu formei duas conclusões:primeiro, que Jesus Cristo está vivo; em segundo lugar, que a Bíblia é um verdadeiro, e relevante, Livro atualizado. Estas conclusões alteraram todo o curso da minha vida”.Ele é autor de mais de 50 livros, de 600 mensagens em áudio e em vídeo e 100ensinamentos muitos dos quais foram traduzidos e publicados em mais de 100idiomas. Prince faleceu, em 24 de setembro de 2003, devido a uma insuficiênciacardíaca, enquanto dormia em sua casa, em Jerusalém.

Nuestro espacio musical semanal, "El ritmo continúa", lanza un guiño en su última edición de 2025 a algunos de los pioneros leoneses que, hace alrededor de seis décadas, empezaron a importar y desarrollar en nuestra provincia los sonidos propios de la música moderna que ya imperaban en la escena internacional. Bajo esa premisa Kike Cardiaco recupera clásicos del repertorio de Los Tricolores, The Rolls y Roberto Lana.

Organiza tu trabajo y aymenta tu productividad con Odoo

AI is transforming how work happens and redefining what it means to lead. Moderna's Tracey Franklin, chief people and digital technology officer, and Heidrick & Struggles' Katie Graham Shannon, global head of the Digital and Technology Officers Practice, discuss how organizations are uniting people, technology and strategy to build new capabilities, foster innovation, and unlock enterprise value. They share how forward-looking leaders are reimagining roles, empowering teams and shaping a more connected and adaptive future workforce.

In this conversation, Heidi Harris interviews Kayla Pollock, who shares her harrowing experience of being injured by the COVID-19 vaccine. Kayla recounts her active life before the vaccine, the decision to get vaccinated under pressure, and the devastating side effects that led to her quadriplegia. She discusses her hospital experiences, misdiagnoses, and the challenges of navigating the healthcare system in Canada. The conversation also touches on the legal actions Kayla is pursuing for compensation and the disturbing trend of medical assistance in dying being offered to patients in similar situations. In this conversation, the speaker shares her harrowing journey through vaccine injury, the challenges of navigating dependency on social support systems, and the emotional toll of considering medical assistance in dying. She discusses the importance of sharing her story publicly, the gaslighting experienced from those who have been vaccinated, and the ongoing legal battle against vaccine manufacturers. The conversation highlights the duty of care and transparency that medical manufacturers owe to patients, as well as the profound impact of these experiences on family life and personal growth.To donate to her Kayla: www.opkayla.ca/donateFind Kayla: @KCpollockHer website: https://www.opkayla.caMy podcast is now on Spotify! Just search “Heidi Harris Show” and check it out!Get on my email list: Go to HeidiHarrisShow.com and click on “message the show”! The audio version of my book “Don't Pat me on the Head!” is now available at heidiharrisshow.com! HeidiHarris.comHeidiHarrisShow.comHeidi@HeidiHarris.comPodcast: Heidi Harris Show (Spotify, or anywhere you get podcasts) @HeidiHarrisShowInstagram: Heidi Harris ShowRumble: Heidi Harris Show (videos)Youtube: Heidi Harris ShowBooks: Don't Pat me on the Head! Blowback, Setbacks and Comebacks in Vegas radiohttps://www.amazon.com/Dont-Pat-Me-Head-Comebacks/dp/1984195263/ref=sr_1_1?crid=3QWT1L4CYAGUH&keywords=dont+pat+me+on+the+head&qid=1698428860&s=books&sprefix=dont+pat+me+on+the+head%2Cstripbooks%2C175&sr=1-1Cocktail Waitress Wisdom; Life Lessons Learned While Carrying a Tray in Las Vegashttps://www.amazon.com/Cocktail-Waitress-Wisdom-lessons-carrying/dp/0982983506/ref=sr_1_1?crid=XFT6XYR0G752&keywords=cocktail+waitress+wisdom&qid=1698428901&s=books&sprefix=cocktail+waitresss+wisdom%2Cstripbooks%2C169&sr=1-1

Angel Studios https://Angel.com/HermanJoin the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability.  Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here! Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeJenner Furst, director of the latest Angel Studios documentary "Thank You Dr. Fauci" joins the show.Episode Links:Thank You Dr. Fauci | Now Streaming | AngelBREAKING/URGENT: mRNA COVID VACCINES KILLED AT LEAST 10 KIDS, THE FDA REPORTS; An FDA review found the shots to blame for the deaths, FDA's new vaccine chief - Dr. Vinay Prasad - told staffers in an email. The agency will tighten standards on new vaccine approval, Prasad wrote.Fauci's Ebola stuntURGENT: mRNA Covid jabs should NEVER have been approved for children or young adults Pfizer, Moderna, the Biden Administration, and everyone in public health who pushed these for kids and teens have blood on their handsUnmask The Truth | Official Clip | Thank You, Dr. Fauci

Paypal: https://www.paypal.com/paypalme/editorialtpv El día de hoy hablaremos sobre el capítulo 5 del libro The Oxford Handbook of Christmas, titulado “The Twentieth and Twenty-First Centuries,” por Christopher Ferguson. Ver aquí: https://global.oup.com/academic/product/the-oxford-handbook-of-christmas-9780198831464?cc=gb&lang=en& Articulo: https://semperreformandaperu.org/2025/12/22/mas-alla-de-los-villancicos-la-sorprendente-y-conflictiva-historia-moderna-de-la-navidad/ Video: https://youtu.be/fr4VlvtXJSc  PPT: https://semperreformandaperu.org/wp-content/uploads/2025/12/navidad_un_espectro_de_historias.pdf  La Navidad del siglo XX no fue solo una fiesta: fue un escenario global donde se cruzaron imperios, migraciones, guerras, medios masivos y, sobre todo, una tensión persistente entre “Navidad cultural” y “Navidad cristiana”. En este episodio, siguiendo el capítulo de Christopher Ferguson, rastreamos cómo el festejo se expandió “alrededor del mundo” de un modo sin precedentes: llevado por colonos, misioneros, comercio y, más tarde, por radio, cine, televisión y la web.   Pero la globalización no fue homogénea. La Navidad se nacionalizó (con “estilos” ingleses o alemanes) y luego se estandarizó en parte por la influencia económica y mediática de Estados Unidos, desde luces eléctricas hasta una imagen internacional cada vez más uniforme de Santa. En paralelo, la política la instrumentalizó: desde la propaganda de regímenes totalitarios hasta el uso simbólico de árboles y villancicos en contextos de Guerra Fría; y la guerra la marcó con escenas inolvidables, como la determinación de celebrar en trincheras, campos de prisioneros o ciudades bombardeadas.   También miramos conflictos más íntimos: la ansiedad por la secularización, el peso de la logística navideña en los hogares, y la obsesión moderna por una “Navidad auténtica” que, paradójicamente, cambia cada década. Si quieres entender por qué la Navidad moderna es tan amada como disputada, aquí está la clave histórica. 

Fue todo un icono del cuplé, de la cultura y de la sofisticación. Hoy traemos a nuestro cronovisor la figura de la Fornarina. Jesús Callejo nos hablará de todos sus secretos. Luego viajamos a Córdoba para visitar la exposición El despertar a la vida, en donde se nos describe cómo era la vida de los niños y niñas en el antiguo Egipto. Lo hacemos con una de sus comisarias, la egiptóloga Esther Pons. Miguel Lázaro nos trae una nueva sección de Discos con historia de la mano de Led Zeppelin. Acabamos el programa en la guerra de Vietnam con David López Cabia, quien acaba de publicar Callejones sin gloria en donde se nos cuenta la historia de la batalla de Hue

Paypal: https://www.paypal.com/paypalme/editorialtpv El día de hoy hablaremos sobre el capítulo 4 del libro The Oxford Handbook of Christmas, titulado “The Nineteenth Century,” por Timothy Larsen. Ver aquí: https://global.oup.com/academic/product/the-oxford-handbook-of-christmas-9780198831464?cc=gb&lang=en& Articulo: https://semperreformandaperu.org/2025/12/19/como-el-siglo-xix-realmente-invento-la-navidad/ Video: https://youtu.be/LpY9bkOnO78  PPT: https://semperreformandaperu.org/wp-content/uploads/2025/12/navidad_el_rio_de_cuatro_corrientes.pdf  ¿De verdad la Navidad estaba muriendo antes de 1843 y Charles Dickens la resucitó? Este episodio entra en el siglo XIX para poner esa historia contra la evidencia. A partir del capítulo “The Nineteenth Century”, seguimos cómo la Navidad ya era una festividad importante en Inglaterra en las primeras décadas del siglo, y cómo ciertos argumentos “clásicos” (por ejemplo, el supuesto silencio anual de The Times) se desmoronan al revisar los datos y el contexto editorial de la época.   Luego examinamos lo que sí cambió: la expansión y reconfiguración de la fiesta en clave victoriana. La Navidad se volvió más amplia y más densa: crecieron sus marcas domésticas (familia, infancia, regalos, árbol), su infraestructura cultural (villancicos, decoración, tarjetas), y su dimensión moral (caridad y responsabilidad social en un mundo industrial).   El capítulo también muestra un giro poco reconocido: la progresiva aceptación de la Navidad por parte de protestantes reformados y disidentes, que antes la rechazaban como “no bíblica”, pero terminaron incorporándola —a veces por la presión social, a veces por dinámicas de ministerio infantil y escuela dominical.   Finalmente, rastreamos dos símbolos decisivos: Santa Claus y el árbol, ambos difundidos en gran medida por redes cristianas y por tradiciones protestantes alemanas. La Navidad moderna no nació de la nada: fue una transformación acumulativa. 

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of groundbreaking advancements, revealing a landscape rich with scientific innovation and strategic maneuvers poised to impact patient care and the drug development pipeline.Let's start with Johnson & Johnson's recent FDA approval for a subcutaneous version of Rybrevant, their lung cancer medication. This new formulation offers a more convenient administration method compared to AstraZeneca's Tagrisso, intensifying competition in the non-small cell lung cancer market. The shift towards more patient-friendly delivery systems underscores the industry's commitment to enhancing treatment adherence and convenience. In contrast, Insmed faced a setback with its phase 2 trial for Brinsupri in treating chronic rhinosinusitis without nasal polyps. The discontinuation of this program highlights the unpredictable nature of clinical trials and emphasizes the need for rigorous scientific validation before advancing therapeutic candidates.Meanwhile, Lilly has shown promising results with its oral obesity pill, marking significant progress in weight management therapies. Patients transitioning from injectable GLP-1 therapies to Lilly's oral drug candidate maintained substantial weight loss, positioning Lilly favorably against Novo Nordisk's Wegovy. The potential for oral formulations to revolutionize treatment paradigms in chronic conditions cannot be understated. Lilly's progress in obesity treatment with its oral medication orforglipron further cements its competitive edge. Participants in their Phase III clinical trial maintained weight loss after switching from Wegovy or Zepbound to orforglipron, suggesting an efficacious oral alternative to injectable treatments and potentially enhancing patient adherence.On the regulatory front, the Biosecure Act's progression within a major defense spending bill could impose new challenges for life sciences companies with Chinese affiliations. This legislative shift reflects geopolitical tensions impacting global pharmaceutical collaborations and underscores the importance of regulatory compliance in international partnerships. Similarly, Intercept Pharmaceuticals' restructuring following the withdrawal of Ocaliva from the U.S. market is indicative of strategic pivots in response to regulatory hurdles and evolving market dynamics.In dermatology, Takeda's successful phase 3 trials for Zasocitinib highlight the competitive nature of drug development as multiple players vie for market share within therapeutic areas. Their anticipated 2026 FDA filing underscores the prolonged timelines involved in bringing novel therapies to market despite successful clinical outcomes.Public-private collaborations continue to play a crucial role in vaccine development, as evidenced by Moderna's pandemic influenza vaccine advancement into phase 3 trials with support from the Coalition for Epidemic Preparedness Innovations (CEPI). This $54 million investment illustrates ongoing efforts to bolster pandemic preparedness through innovative mRNA technologies. Meanwhile, Moderna's $54 million funding from CEPI to advance its bird flu vaccine highlights resilience amidst fluctuating governmental support. This endeavor leverages Moderna's mRNA technology platform, emphasizing mRNA's versatility across various infectious diseases.Shifting our focus slightly, medical groups have expressed opposition to changes in hepatitis B vaccination recommendations by the CDC for newborns. Such policy debates have significant implications for public health strategies and highlight ongoing discussions within medical communities regarding optimal vaccination protocols.GSK's strategic collaboration with Camp4 Therapeutics marks another key industry development. With an investment exceeding $400 million, GSK aims to Support the show

“People are not looking for a perfect, polished answer. They're looking for a human to speak to them like a human,” says Jessica Malaty Rivera, an infectious disease epidemiologist and one of the most trusted science communicators in the U.S. to emerge from the COVID-19 pandemic. That philosophy explains her relatable, judgement-free approach to communications which aims to make science more human, more accessible and less institutional. In this wide-ranging Raise the Line discussion, host Lindsey Smith taps Rivera's expertise on how to elevate science understanding, build public trust, and equip people to recognize disinformation. She is also keen to help people understand the nuances of misinformation -- which she is careful to define – and the emotional drivers behind it in order to contain the “infodemics” that complicate battling epidemics and other public health threats. It's a thoughtful call to educate the general public about the science of information as well as the science behind medicine. Tune in for Rivera's take on the promise and peril of AI-generated content, why clinicians should see communication as part of their professional responsibility, and how to prepare children to navigate an increasingly complex information ecosystem.Mentioned in this episode:de Beaumont Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über ein Ausnahmejahr für Rückversicherer, einen Dämpfer für Rüstungsaktien und Enttäuschung bei Pfizer. Außerdem geht es um Rheinmetall, Renk, Hensoldt, Lufthansa, Easyjet, Warner Bros Discovery, Paramount Skydance, Netflix Pfizer, Moderna, Biontech, Tilray Brands, Swiss Re, Munich Re, Hannover Rück, iShares S&P 500 Insurance ETF (WKN: A0H08K), Rize USA Environmental Impact UCITS ETF (WKN: A3ENMA), iShares MSCI Climate Transition Aware UCITS ETF (WKN: 906866), Lyxor MSCI Green Infrastructure ETF (WKN: LYX0YL), VanEck Sustainable Infrastructure ETF (WKN: A12HWR), Teva Pharmaceutical, Bank Leumi, Bank Hapoalim, Elbit Systems und Check Point Software. Die aktuelle "Alles auf Aktien"-Umfrage findet Ihr unter: https://www.umfrageonline.com/c/mh9uebwm Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Si la Biblia es la Palabra de Dios, ¿por qué no menciona temas científicos modernos como la capa de ozono, la genética, el calentamiento global o la posibilidad de vida extraterrestre?En este episodio explicamos qué es la Biblia, cuál es su propósito real y por qué no debemos esperar que responda preguntas científicas contemporáneas. También exploramos la relación entre revelación divina, ciencia y adoración.Envía tus preguntas a: preguntas@verdadyfe.comConecta con nosotros aquí: https://linktr.ee/verdadyfe

✨ Apoya nuestro podcast y disfruta sin interrupciones ✨ Si valoras nuestro contenido, ayúdanos a seguir creando más episodios y, como agradecimiento, escucha Estoicismo Filosofía Premium sin anuncios.

Masada-klippan och den befästa fästningen där de judiska seloterna gjorde sitt sista motstånd mot Romarriket har en närmast mytologisk betydelse i dagens Israel. Fortfarande svär unga israeliska soldater sin trohet uppe på Masada – en plats som blivit en symbol för motstånd, offer och nationell identitet.Det judiska upproret, som inleddes år 66 e.Kr., blev en katastrof för det judiska folket. År 70 förstördes Jerusalem i grunden av romarna, och den sista fasen av upproret utspelade sig på Masada. Under åren 73–74 belägrades fästningen av den romerska armén i en militär operation som fortfarande imponerar historiker. Genom att anlägga en enorm ramp uppför berget och omringa platsen med ett system av läger och vallar tvingade romarna de judiska försvararna till ett sista desperat beslut.I detta avsnitt av Militärhistoriepodden diskuterar Martin Hårdstedt och Peter Bennesved den dramatiska slutstriden vid Masada. Belägringen är inte bara central i berättelsen om de judiska upproren, utan även ett unikt exempel på romersk belägringsteknik. Rester av romarnas anläggningar – vallarna, lägren och framför allt den väldiga rampen – finns ännu kvar och ger oss en sällsynt inblick i antikens krigskonst.Den mest omdiskuterade aspekten av Masada är berättelsen om det kollektiva självmord som enligt den judiske historikern Flavius Josefus ska ha ägt rum, där seloterna valde döden framför romerskt slaveri. Men hur pålitlig är denna källa? Moderna forskare menar att berättelsen måste tolkas med försiktighet – det finns inga oberoende bekräftelser på att självmordet faktiskt ägde rum.Konsekvenserna av de judiska upproren blev ödesdigra. Det judiska folket skingrades, och en lång exil inleddes. Först mot slutet av 1800-talet väcktes idén om en återkomst till det historiska hemlandet, och det var först år 1948 som staten Israel grundades. Masada lever kvar – som symbol och myt, men också som ett fysiskt monument över romersk krigföring och judiskt motstånd.Bildtext: Masada är en symbol för judiskt motstånd och är mest känd för det romerska belägringsdramat år 73 e.Kr. Platsen är idag ett världsberömt arkeologiskt monument och ett UNESCO-världsarv. Foto: Andrew Shiva / Wikipedia. Licens: CC BY-SA 4.0.Klippare: Emanuel Lehtonen Hosted on Acast. See acast.com/privacy for more information.

Algunas producciones de la etiqueta norteamericana Víctor, editadas en la frontera de los años 30 a los 40 del siglo XX, nos permitirán revivir el fenómeno de la "cubanización" de las orquestas jazz bands. La orquesta Hermanos Castro con su cantante Miguelito García, Miguelito Valdés con la Casino de la Playa, Cascarita con la orquesta Hermanos Palau y Reinaldo Valdés "el jabao" con la orquesta del trompetista Julio Cueva nos acercan algunos clásicos de la música popular cubana. A continuación, y a propósito de la evolución de los jazz bands en la isla, un recuerdo para uno de los grandes artífices de este formato orquestal: el pianista, arreglista y compositor Ernesto Duarte. Fernando González, Tata Ramos y Rolo Martinez, grabados y producidos por el talentoso músico para su etiqueta "Duarte" llegan con la sonoridad del jazz band de los últimos años 50. Junto al contrabajista Cachao López y otros notables instrumentistas como Alejandro "el negro" Vivar en trompeta, Generoso "Tojo" Jiménez en trombón, Rogelio "Yeyito" Iglesias en los bongoes, Guillermo Barreto en pailas, Niño Rivera en el tres, Tata Güines en las tumbadoras, volvemos a los míticos estudios de Panart y a las "descargas en miniatura" que, finalizando los 50, permitieron cristalizar la categoría del jazz en el panorama discográfico cubano. En ese sentido las producciones "Tropicana", propiciadas por el genio de la emisora CMOX: Adolfo Seeman, constituyeron un paso más en el desarrollo en la discografia en función de darle más consistencia a la llamada "descarga". Frank Emilio a la cabeza del "Quinteto de Música Moderna", impulsado comercialmente por Seeman, con la complicidad de Papito Hernández en contrabajo, Gustavo Tamayo en güiro, Tata Güines en las tumbadoras y Guillermo Barreto en drum y pailas. En la despedida, y de vuelta al catálogo RCA Víctor, revisitamos el debut discográfico del Benny Moré como parte del conjunto Matamoros. Las maravillas de la música popular cubana, todos los domingos, las reservamos aquí para ti.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a myriad of transformative advancements and strategic shifts within these industries, illustrating the profound impact of innovation and regulatory changes on healthcare.Eli Lilly's recent strides in obesity treatment highlight a significant scientific breakthrough with their novel drug, retatrutide. Currently in phase 3 trials, this triple agonist targets GLP-1, GIP, and glucagon receptors, achieving an extraordinary 28.7% weight loss in participants. Additionally, it demonstrated a 75.8% reduction in knee osteoarthritis pain. Yet, the journey to this milestone wasn't without challenges. The trials saw a higher discontinuation rate than earlier studies, reminding us of the delicate balance between efficacy and patient tolerability—a consistent theme in obesity pharmacotherapy as developers strive to maximize benefits while minimizing adverse effects.In a testament to the global nature of drug development, Zealand Pharma has embarked on a $2.5 billion collaboration with a burgeoning Chinese biotech firm. This partnership aims to advance oral cardiometabolic therapies, underscoring the crucial role of strategic alliances in accessing innovative scientific platforms and expanding market reach.Rezolute faced a significant setback with a disappointing phase 3 trial for its hypoglycemia treatment, resulting in an 87% drop in stock value. This starkly illustrates biotech's inherent volatility and the critical importance of robust clinical trial design to mitigate financial risks associated with unsuccessful outcomes.Meanwhile, Moderna is leveraging Nanexa's expertise in long-acting formulations to enhance injectable therapy delivery systems. This collaboration is indicative of a broader industry trend focused on optimizing drug delivery technologies to boost efficacy and patient compliance.Operational restructuring is also evident as Pfizer implements cost-cutting measures, including layoffs in Switzerland, as part of broader strategic initiatives to optimize operations amid rising R&D costs and pricing pressures. Simultaneously, Chris Boulton's transition from Amgen to Prolynx underscores the fluid movement of talent within the industry—a reflection of ongoing strategic realignments.Regulatory landscapes are shifting as well. The FDA's approval of the first non-drug at-home treatment for depression marks an expansion into alternative therapeutic modalities beyond traditional pharmaceuticals. This wearable device offers adults with major depressive disorder a novel treatment option, integrating technology into mental health care—a promising addition to holistic treatment strategies.In another significant regulatory update, Teva Pharmaceuticals agreed to delist numerous patents from the FDA's Orange Book following an FTC ruling. This move is anticipated to foster increased generic competition and potentially lower medication costs for conditions like asthma and diabetes—a critical shift towards greater market accessibility.The FDA has also finalized guidance on promotional materials for biologics and biosimilars, standardizing advertising practices to ensure accurate representation of these products' efficacy and safety profiles amidst an expanding biologics market.Moreover, the FDA has launched its Commissioner's National Priority Voucher Pilot Review Program to expedite critical drug approvals. The first beneficiary under this program was USAntibiotics with Augmentin XR, signaling a potential shift towards more rapid access to essential medications.On the international policy front, recent developments between the UK and US have led to reductions in medicine rebate rates within the UK. This adjustment could lead to increased spending on new medicines, indicating more favorable conditions for pharmaceutical Support the show

“Delivering a baby one day and holding a patient's hand at the end of life literally the next day...that continuity is very powerful,” says Dr. Jen Brull, board chair of the American Academy of Family Physicians (AAFP). And as she points out, that continuity also builds trust with patients, an increasingly valuable commodity when faith in medicine and science is declining. As you might expect given her role, Dr. Brull believes strengthening family medicine is the key to improving health and healthcare. Exactly how to do that is at the heart of her conversation with host Lindsey Smith on this episode of Raise the Line, which covers ideas for payment reform, reducing administrative burdens, and stronger support for physician well-being. And with a projected shortage of nearly forty thousand primary care physicians, Dr. Brull also shares details on AAFP's “Be There First” initiative which is designed to attract service-minded medical students – whom she describes as family physicians at heart -- early in their educational journey. “I have great hope that increasing the number of these service-first medical students will fill part of this gap.”Tune-in for an informative look at a cornerstone of the healthcare system and what it means to communities of all sizes throughout the nation.  Mentioned in this episode:AAFP If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Recibe tu curso gratis aquí: https://www.hombrealfa.top/curso-gratis/ Únete a los miles de hombres que forman parte de mi comunidad de email para acceder a promociones exclusivas y enterarte de la apertura de mis formaciones. Estar suscrito tiene premio y es la única manera de estar al día de las novedades del proyecto. Al suscribirte con tu email, recibes el curso gratis de «Cómo ser un hombre más atractivo e interesante para las mujeres en la era de las apps y las redes sociales». Es un curso de siete lecciones por escrito (no vídeo, no audio) que puedes personalizar en función del momento que estés viviendo en tus relaciones. Para unirte a mi comunidad y recibir el curso, deja tu email en el enlace: https://www.hombrealfa.top/curso-gratis/ *¿Qué aprenderás en este episodio?: 1) El error más común que cometen incluso los hombres casados durante décadas. 2) Por qué una mujer puede quererte... y aun así irse con otro. 3) La verdad biológica que ningún gurú Red Pill se atreve a decirte. 4) Cómo cambia el deseo femenino según su ciclo menstrual (y por qué deberías saberlo). 5) Qué debes entender (y desaprender) para elegir una relación monógama desde tu marco. En este episodio desenmascaramos uno de los mayores tabúes que existen hoy sobre las mujeres: su estrategia reproductiva dual. ¿De verdad buscan al chico malo solo cuando son jóvenes? ¿Y qué pasa cuando se casan? ¿Cambian realmente sus preferencias? Vamos a tirar abajo décadas de cuentos femeninos y falsas Red Pill basándonos solo en biología evolutiva y estudios reales. Porque si no entiendes la hipergamia desde la raíz, acabarás como tantos hombres: perdido, traicionado y sin saber qué ha fallado. PD. Recibe tu curso gratis aquí: https://www.hombrealfa.top/curso-gratis/

Dirige y presenta: Juan Carlos Baruque Hernández Sumario del programa MIGUEL ÁNGEL RUIZ *Las nuevas conspiraciones. *Conspiraciones modernas. Nuestra Web: https://mundoinsolitoradio.es Contacta: +34 687 39 80 12 - Solo WhatsApp mundoinsolitoradio@hotmail.com Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

Michael Jordan never won an NBA championship until he was paired with the right coach. Then, he won six. Could working with a coach change your MS journey? In this week's episode, health & wellness coach Amy Behimer explains what health coaching is all about and how working with a coach might impact someone living with MS. We're also sharing study results that show DMTs fail to manage MS-related pain. Then, we'll explain how a common misconception can lead to the wrong outcome for someone with MS. And we'll share study results showing that adhering to the Mediterranean or MIND diet improves cognitive performance among people living with MS. We'll also explain why this study raises as many questions as it seeks to answer. We have a lot to talk about! Are you ready for RealTalk MS??! Thank you!  :22 This Week: What working with a health coach is all about  1:08 Study results show that disease-modifying therapies don't help manage MS-related pain (But are they supposed to???)  2:29 Study results show that adhering to the Mediterranean or MIND diet improves cognitive performance among people with MS (Or does it??)  5:13 Health & Wellness Coach Amy Behimer explains how someone living with MS could benefit from coaching  12:11 Share this episode  39:33 Next week's episode  39:53 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/432 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com DONATE: The National MS Society https://nationalmssociety.org/donate SIGN UP: Become an MS Activist https://nationalmssociety.org/advocacy STUDY: Phase 2 Clinical Trial for Moderna's EBV Vaccine and MS https://www.msard-journal.com/article/S2211-0348(25)00573-5/fulltext STUDY: Mediterranean and MIND Diet Patterns and Cognitive Performance in Multiple Sclerosis: A Cross-Sectional Analysis of the UK Multiple Sclerosis Register https://www.mdpi.com/2072-6643/17/21/3326 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 432 Guests: Amy Behimer Privacy Policy

Per approfondire gli argomenti della puntata: Altre pillole dedicate all'Età Moderna : https://www.youtube.com/watch?v=04jMzzw0qK4&list=PLpMrMjMIcOkkxE3VRfoFOph9H6S2v2Njr&ab_channel=LaBibliotecadiAlessandria Learn more about your ad choices. Visit megaphone.fm/adchoices

Angel Studios https://Angel.com/HermanJoin the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability.  Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeJenner Furst, director of the latest Angel Studios documentary "Thank You Dr. Fauci" joins the show.Episode Links:Thank You Dr. Fauci | Now Streaming | AngelBREAKING/URGENT: mRNA COVID VACCINES KILLED AT LEAST 10 KIDS, THE FDA REPORTS; An FDA review found the shots to blame for the deaths, FDA's new vaccine chief - Dr. Vinay Prasad - told staffers in an email. The agency will tighten standards on new vaccine approval, Prasad wrote.Fauci's Ebola stuntURGENT: mRNA Covid jabs should NEVER have been approved for children or young adults Pfizer, Moderna, the Biden Administration, and everyone in public health who pushed these for kids and teens have blood on their handsUnmask The Truth | Official Clip | Thank You, Dr. Fauci

What are CEOs across industries doing to build resilience and strong cultures in an age of uncertainty? In this Future of Business series, IdeaCast hosts Alison Beard and Adi Ignatius sat down with four leading CEOs to understand where global business is going. In this episode, host Alison Beard speaks with Noubar Afeyan, the CEO of Flagship Pioneering and Chairman of Moderna. Afeyan shares the organizational models and practices that work best to produce innovation, the difference between managing risk and managing uncertainty, and what separates true breakthrough innovation from everyday, incremental improvements.

“This is a time to reimagine public health and public health/healthcare system integration,” says Dr. Deb Houry, the former chief medical officer for the US Centers for Disease Control and Prevention. In this thoughtful Raise the Line conversation, Dr. Houry reflects on unprecedented federal action in vaccine guidance and other issues since her noteworthy resignation from the CDC in August, and sees a more decentralized landscape emerging where states and localities play a larger role in providing public health recommendations. And while she acknowledges upsides to this shift, she's also concerned what the absence of a national consensus on health standards could mean. “Diseases don't recognize borders, and it's also important that people have equitable access to preventative services, vaccines, and other things,” she tells host Lindsey Smith. Tune in for Dr. Houry's seasoned perspective on this consequential moment in public health, and her encouraging message for learners and early career providers considering a career in the sector.Mentioned in this episode:DH Leadership & Strategy Solutions If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Chuck And Julie Show with Chuck Bonniwell and Julie Hayden Guest, Ray Garcia - CO GOP Chair Brita Horn continues to steer the Colorado Republican Party toward disaster As CO GOP Chair Brita Horn continues to steer the Party toward disaster, grassroots warrior Ray Garcia renews his call for changes in leadership. He joins the show to reveal the latest efforts. Plus shocking FDA memo reveals Moderna knew its COVID 19 vaccine killed children and joined forces with the government to coerce vaccinations anyway.

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über drohenden Ärger für Moderna, einen Kurskracher bei MongoDB und fiese Japan-Vibes. Außerdem geht es um Moderna, BioNTech, Novavax, Pfizer, GSK, MongoDB, Cleanspark, Coinbase, Robinhood, Strategy, Bitcoin, Ether, Bayer, Synopsis, Nvidia und The Magnum Ice Cream Company. Die aktuelle "Alles auf Aktien"-Umfrage findet Ihr unter: https://www.umfrageonline.com/c/mh9uebwm Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Em 2025, Data destaca a subida global dos casos de escravidão moderna e reforça o apelo do secretário-geral para ações urgentes que protejam os 50 milhões de vítimas atuais.

Ohne Aktien-Zugang ist's schwer? Starte jetzt bei unserem Partner Scalable Capital. Mit eigenem KI-Chatbot, der dir alle Fragen rund ums Investieren beantwortet. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Goldman Sachs kauft ETF-Anbieter. NVIDIA investiert in Synopsys. Rüstungsaktien fallen wegen Friedensgesprächen. Airbus hat Produktionsprobleme. Moderna & BioNTech kämpfen mit Regulatorik. Coupang hat Datenleck. Bitcoin verliert. Disney gewinnt. Schwierige wirtschaftliche Zeiten. Hohe Inflation. Darunter leiden viele. TJX (WKN: 854854) profitiert. Die Gen Z will schlichtere Luxusuhren. Cartier freut's. Richemont (WKN: A1W5CV) auch. Lohnt ein Investment noch? Diesen Podcast vom 02.12.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

At the age of 14, Michaela Janssen Pohl became a caregiver for her mother, who lives with MS. I think most of us can agree that just being a teenager carries with it more than enough challenges. Those adolescent years are the years when just about everything in life starts changing. Imagine adding the responsibilities of being a caregiver to all the other things going on in a 14-year-old girl's life. Michaela joins me this week to explain how she found ways to survive and thrive in what can only be described as a challenging situation for any teenager. We'll also explain why you might want to think a little differently about Giving Tuesday this year. We're sharing all the details about the Phase 2 clinical trial focusing on Moderna's investigational Epstein-Barr vaccine and MS (and we'll explain why that might turn out to be important!) We're talking about how MS impacts women's health issues with this year's winner of the Rachel Horne Prize for Women's Research in Multiple Sclerosis, Dr. Kristen Krysko. And we're sharing the results of the Phase 2 clinical trial for PIPE-307, an investigational remyelination therapy. We have a lot to talk about! Are you ready for RealTalk MS??! It's Giving Tuesday (and why that matters more this year than ever before)  :22 This Week: Becoming a caregiver for a parent with MS when you're 14 years old  3:27 A clinical trial focused on an EBV vaccine and MS is recruiting participants  4:25 Dr. Kristen Krysko discusses MS and women's health issues  7:52 Results from the Phase 2 clinical trial for PIPE-307 remyelination therapy  13:48 Michaela Janssen Pohl shares her story of becoming a caregiver at the age of 14  16:55 Share this episode  33:20 Next week's episode  33:40 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/431 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com DONATE: The National MS Society https://nationalmssociety.org/donate SIGN UP: Become an MS Activist https://nationalmssociety.org/advocacy PARTICIPATE: Phase 2 Clinical Trial for Moderna's EBV Vaccine and MS https://clinicaltrials.gov/study/NCT06735248 Email: WeCareClinicalTrials@modernatx.com JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 431 Guests: Dr. Kristen Krysko, Michaela Janssen Pohl Privacy Policy

El lanzaroteño Jorge Cabrera Luzardo, conocido artísticamente como Jorge Caluz, es cantante, pianista y compositor. Su discapacidad visual, apenas un 10% de visión, nunca le ha frenado a la hora de dedicarse a lo que más le apasiona: la música. Al contrario, potenció desde pequeño su sensibilidad y su oído musical.Comenzó a estudiar piano con tan solo 3 años y a los 15 inició su formación en canto. Más tarde prosiguió estudios superiores en Música Moderna e Interpretación Vocal en Madrid y Londres. Ha actuado en escenarios tan emblemáticos como la Sala Sol de Madrid y, desde hace dos años, ofrece conciertos en solitario.En 2025 ha representado a España en el Certamen Internacional “Low Vision”, considerado el “Eurovisión” de los artistas con discapacidad visual. En esta ocasión nos interpreta en directo una composición propia: Mi forma de ser.Escuchar audio

Australia is known around the world for its rich and diverse First Nations cultures. But when it comes to native title and land rights, you might still wonder what they actually mean. Discover what native title means in Australia, how it began with the Mabo Case, what the Native Title Act does, and why it matters for all Australians. - Australia es conocida en todo el mundo por sus ricas y diversas culturas de las Primeras Naciones. Pero cuando se trata de los títulos nativos y los derechos sobre la tierra, es posible que aún te preguntes qué significan realmente. Descubre qué significa el título nativo en Australia, cómo comenzó con el caso Mabo, qué hace la Ley de títulos nativos y por qué es importante para todos los australianos.

Selamat pagi! Today, travel medicine specialists Drs. Paul Pottinger & Chris Sanford answer your travel health questions, including:Myocarditis & Moderna–is the risk real?Is Waymo a safe way to get around?West Nile Virus in France–really?What changes are coming up with regulations for European travel?What should I know about leptospirosis to stay safe?What Travel apps do you recommend?How can I get my health insurance to cover pre-travel office visits?How do you recommend I learn a new language quickly?We hope you enjoy this podcast! If so, please follow us on the socials @germ.and.worm, subscribe to our RSS feed and share with your friends! We would so appreciate your rating and review to help us grow our audience. And, please visit our website: germandworm.com where you can find all our content and send us your questions and travel health anecdotes. Or, just send us an email: germandworm@gmail.com.Our Disclaimer: The Germ and Worm Podcast is designed to inform, inspire, and entertain. However, this podcast does NOT establish a doctor-patient relationship, and it should NOT replace your conversation with a qualified healthcare professional. Please see one before your next adventure. The opinions in this podcast are Dr. Sanford's & Dr. Pottinger's alone, and do not necessarily represent the opinions of the University of Washington or UW Medicine.

“My most powerful content is when I lead with my voice as a mom because I have the same concerns about keeping my kids safe as my audience does. It's a powerful and effective way to find common ground with people,” says Dr. Jess Steier, a popular public health scientist and science communicator seeking to bridge divides and foster trust through empathetic, evidence-based communication. Dr. Steier has several platforms from which to do this work, including  Unbiased Science --  a communication hub that uses multiple social media platforms and other communications channels to share validated health and science information -- and as executive director of the Science Literacy Lab, a nonprofit organization dedicated to reaching a diverse audience seeking clarity and reliable information on scientific topics. “The science is less than half the battle,” she explains. “It's about how to communicate with empathy.”Join Raise the Line host Lindsey Smith for a valuable conversation that explores:What sources Dr. Steier relies on to validate informationHow she uses “escape room” exercises to train clinicians on empathetic communicationWhy tailored, story-driven messages reach audiences more effectively than facts.Mentioned in this episode:Unbiased Science If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

What does it really take to launch a big idea? One that can change your career, business, or even the world? Is being a visionary enough, or is there a hidden formula for success? Guest Jen Kem says it's all about building the right "unicorn team." But here's the twist: even if you're a solopreneur or running a small business—like me—this book is still for you. Jen's framework isn't about having a massive team; it's about understanding the roles and energies you bring to your work and how to fill in the gaps to achieve success faster and with less burnout.Jen is a brand strategist, entrepreneur, and author of Unicorn Team: The Nine Leadership Types You Need to Launch Your Big Ideas with Speed and Success. With a career working on iconic initiatives for companies like Microsoft, Coca-Cola, and Oracle, she's now revealing how big ideas succeed—not just through visionaries, but through the right mix of leaders who execute and get results.We'll learn how to identify your own leadership type, how even a solo effort can become a "team" by leveraging the right resources, and hear the inspiring story of how a small team at Moderna outpaced industry giants to lead the charge on a life-saving vaccine. Hosted on Acast. See acast.com/privacy for more information.

En Raza Deportiva Rafa Ramos y Eli Patiño analizan la ‘resurrección' de Chicharito y profundizan en las dos caras de Javier Hernández, además reaccionan a la jornada 17 de la Liga MX: triunfo de Pumas, derrota del América y la victoria de Guadalajara sobre Monterrey. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Unredacted government emails obtained by Senator Ron Johnson show that health officials identified a myocarditis risk from mRNA vaccines months before informing the public. While Pfizer and Moderna were quietly notified, Americans were not. Jefferey Jaxen breaks down the evidence and new studies showing how mRNA and spike proteins affect heart tissue. Del Bigtree calls it a defining moment for accountability in public health.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.